Singhal Priya's Form 4 filing
Biogen Inc.BIIB · filed Jul 5, 2023
- Accession no.
- 0001127602-23-020235
- Filed
- Jul 5, 2023
- Trade date
- Jun 30-Jul 3, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $22.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | Common Stock | MOption exerciseAcquired | +315 | $0.00 | $0 | 3,158.09 | Direct | |
| Jun 30, 2023 | Common Stock | FTax withholdingDisposed | −153 | $284.85 | −$43,582.05 | 3,005.09 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −81 | $282.87 | −$22,912.47 | 2,924.09 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | Common Stock | MOption exerciseDisposed | −315 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.